Additional approvals such as China and Cansino… Increased to 4 approved vaccines

© AFP=News1 material photo

The Chinese Medicines Agency announced on the 25th that it has approved the general use of two additional vaccines for novel coronavirus infection (Corona 19). This increased the number of vaccines approved in China to four.

According to Reuters, the newly approved vaccine is a product developed by the Wuhan Biological Products Research Center under Sinoparm (National Pharmaceutical Group) and Kansino Biologics.

Earlier, the Wuhan Research Institute announced that the prevention effect was 72.51% as a result of phase 3 of its vaccine. The preventive effect of cansino was 65.28%.

All four approved Chinese vaccines can be distributed and stored at normal refrigeration temperatures, making it an attractive option for developing countries that have difficulty handling Pfizer and modders or vaccines that require cryogenic freezing, Reuters said.

China is already exporting synovac and initial synopam vaccines that were previously approved to each country.

[email protected]